-
IntroducedJun 07, 2023
-
Passed House
-
Passed Senate
-
Signed into Law
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Last Action See all actions
Senate • Sep 24, 2024: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HR 3884
Tweets
Whip Lists
Sponsors
- Rep. Lee, Barbaracosponsor
Votes
Actions
- Sep 24, 2024 | Senate
- Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sep 23, 2024 | House
- Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
- Considered under suspension of the rules. (consideration: CR H5578-5580)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
- Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
- On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
- Motion to reconsider laid on the table Agreed to without objection.
- Aug 25, 2023 | House
- Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
- Placed on the Union Calendar, Calendar No. 132.
- Jul 19, 2023 | House
- Committee Consideration and Mark-up Session Held.
- Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
- Jul 13, 2023 | House
- Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
- Subcommittee Consideration and Mark-up Session Held
- Jun 09, 2023 | House
- Referred to the Subcommittee on Health.
- Jun 07, 2023 | House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.